Drug Company Insider Stock Dumping Surged as Taxpayer-Funded Vaccines Moved Toward Approval

Accountable Pharma released a new report outlining the more than $250 million in insider stock sales by executives and directors at five major drug companies producing vaccines with taxpayer support, including $105 million in new profits from insider sales between September and mid-November.